The CH 2 Cl 2 -MeOH (1:1) extract of a Chilean plant Myrcianthes coquimbensis (Barnéoud) Landrum et Grifo was found to inhibit the growth of Mycobacterium tuberculosis by 73% at a concentration of 50 μg/mL. The bioassay guided separation of this extract led to the isolation of a new monoterpene (1S,3S,4R)-1-methyl-4-(1-methylethenyl)-1,3-cyclohexanediol (3β-hydroxy-cis-β-terpineol, 1), along with oleanolic acid, 3β-caffeoyl-olean-12-en-28-oic acid, trans-(+)-sobrerol, epi-catechin, and catechin. The structure of 1 was determined by GC/MS, and 1D and 2D NMR spectroscopic experiments, and its absolute configuration was established by Mosher's esterification. The antitubercular activities of all isolates were evaluated using the microplate alamar blue assay (MABA). Oleanolic acid was determined to be active with an MIC value of 65.04 μM in MABA and low cytotoxicity to African green monkey vero cells, with an IC 50 value of >224.5 μM, whereas all other isolates were inactive. The CH 2 Cl 2 -MeOH (1:1) extracts of two additional populations of M. coquimbensis procured from different regions in Chile have also been analyzed by LC/MS and the compounds isolated have been identified in these extracts based on retention time, observed LC/MS parent ion, and MS/MS fragmentation pattern.
The alarming increase in the number of deaths due to tuberculosis (TB) and growing resistance to existing drugs has created an urgent need for the identification of leads for new antimycobacterial drugs. Our Latin American International Cooperative Biodiversity Groups (ICBG) Program studies plants from the arid and semi-arid regions of Argentina, Chile and Mexico for their activity against Mycobacterium tuberculosis (MTB). Using this bioprospecting approach to drug discovery, an extract of Myrcianthes coquimbensis (Barnéoud) Landrum et Grifo (Myrtaceae) was found to inhibit the growth of MTB by 73% at a concentration of 50 μg/mL. Based on this important biological activity this plant species was selected for further investigation.
M. coquimbensis was collected in the district of La Serena, Chile, an area which is one of the 25 remaining 'hotspots' of biodiversity [1, 2] . This plant, locally known as "mirto", is used by the local people as a stimulant and as a digestive aid. Limonene has previously been identified by GC/MS as a major component of the volatile leaf oil (14.54 ± 2.45%) of this plant species, followed by carvone (8.67 ± 1.09%) and α and β-pinenes (7.20 ± 0.95 and 5.67 ± 3.35% respectively) [3] . This, to our knowledge, is the first study of the non-volatile components in the genus Myrcianthes and also the first study to determine the active ingredient responsible for the antitubercular activity of the organic extract of M. coquimbensis.
Dried and ground leaves, stem, and fruit of M. coquimbensis (490.7 g) were triturated with 5L n-hexane. The residual plant material (481.2 g) was dried completely and then extracted with CH 2 Cl 2 -MeOH (1:1, 3 L × 2). The CH 2 Cl 2 -MeOH (1:1) extract was observed to inhibit the growth of MTB by 73% at a concentration of 50 μg/mL. Bioassay guided chromatographic fractionation of this extract, as described in the Experimental Section, led to the isolation of a new monoterpene, (1S,3S,4R)-1methyl-4-(1-methylethenyl)-1,3-cyclohexanediol (3βhydroxy-cis-β-terpineol, 1), along with oleanolic acid (2), 3β-caffeoyl-olean-12-en-28-oic acid (3), trans-(+)-sobrerol (4), epi-catechin (5) , and catechin (6) . (75) and 67 (100). The 13 C and DEPT experiments indicated the presence of ten carbons (two methyls, four methylenes, two methines, and two quaternaries). The downfield methylene and quaternary signals at δ 108.9 (C-9) and 148.6 (C-8) respectively, indicated the presence of a terminal di-substituted double bond. Two downfield signals, the methine at δ 74.4 (C-3) and the quaternary at δ 71.7 (C-1), along with the two losses of water observed in the GC/MS suggested the presence of two free hydroxyl groups. The 13 C data, along with the observed molecular ion peak at m/z 170 and fragmentation pattern in the GC/MS, supported a molecular formula of C 10 H 18 O 2 . Compound 1 is a C-3 β-hydroxy derivative of cis-β-terpineol and its 1 H and 13 C NMR spectroscopic data are comparable to the latter [4] . The secondary hydroxy in 1 was assigned to C-3 based on HMBC correlations between the methine proton at δ 3.53 and C-4 (J 2 CH ) and C-1 (J 3 CH ) ( Figure 1 ). The 1 H spectrum was further assigned based on the DQF-COSY experiment.
The relative stereochemistry of compound 1 was assigned based on 1D NOE data ( Figure 1 ). The methyl singlet H-7 was enhanced when the methine proton H-3 at δ 3.53 was excited, allowing for the hydroxy at C-1 as well as C-3 to be assigned as β.
Additionally, H-9a, b were also enhanced when H-3 was irradiated, suggesting that the isopropylene group was α. The absolute configuration of 1 was Figure 2 . Thus, compound 1 was assigned as (1S,3S,4R)-1-methyl-4-(1methylethenyl)-1,3-cyclohexanediol. Stereoisomers of compound 1 have been reported previously by synthetic methods [5] .
Compounds 2-6 were identified as oleanolic acid [6] , 3β-caffeoyl-12-oleanen-28-oic acid [7] , trans-(+)sobrerol [8] , epi-catechin, and catechin [9] by comparing their 1 H and 13 C chemical shift data with those reported in the literature.
LC/MS studies on different populations of M. coquimbensis:
In order to determine the presence of compound 1 and other compounds isolated in this study from M. coquimbensis, as described above, in different populations of the species in our collection, an LC/MS study on their organic extracts was initiated. Two different populations (plants B and C), besides the one reported here to carry out the bioassay directed fractionation (plant A), were available in our collection. All of these plants were collected from the biodiversity 'hotspot' in Coquimbo, Chile [1, 2] , but from different locations, altitudes and at different times over a six-year period, as described in the experimental section. In each collection different plant parts were included, based on the developmental stage of the plant at the time of collection.
The LC/MS study was conducted on the CH 2 Cl 2 soluble fractions (extracts A-C) resulting from a polarity based fractionation, as described in the Experimental Section, of the original CH 2 Cl 2 -MeOH (1:1) extracts of these plants to facilitate detection of minor components by LC/MS. Extracts (A-C) were analyzed by LC/MS/MS using electrospray ionization (ESI) in positive ion mode coupled to an ion trap detector. The samples were run alongside standards of 3β-hydroxy-cis-β-terpineol (1), oleanolic acid (2), trans-(+)-sobrerol (4), and epi-catechin (5) to facilitate detection based on retention time and molecular weight, as well as observed fragmentation.
3β-Hydroxy-cis-β-terpineol (1) was eluted from the HPLC at R t = 20.6 min, detecting at 200 nm. In the MS this corresponded with m/z 193. 3 [M+Na] + . This ion was fragmented to a major fragment at m/z 174.7 [M+Na-H 2 O] + , and other minor fragments. As seen from data presented in Table 2, Table 2 ). Compound 2 was identified at R t ≈ 58.9 min and m/z 439.9 in all three extracts. The fragmentation patterns of all these ions matched the expected fragmentation for compound 2. (4) Antitubercular activity of isolates: All isolates obtained from M. coquimbensis were evaluated for their potential to inhibit the growth of M. tuberculosis and African green monkey Vero cells using established protocols, as described in the Experimental Section. The results suggest that compound 2 afforded growth inhibition with an MIC value of 65.04 μM (control Rifampin was observed to have an MIC value of 0.06 μM in the same assay), whereas the other isolates were virtually inactive (MIC value > 128 μg/mL). When tested for cytotoxicity against a mammalian cell line, 2 was less cytotoxic (IC 50 >224.5 μM) than the positive control rifampin (IC 50 110.27 μM). However, compound 2 had a selectivity index (SI) of 3.45 compared to the SI of 1837 for rifampin. Selectivity Index (SI) is defined as IC 50 /MIC and compounds with SI > 10 are selected as drug leads [10] [11] [12] .
trans-(+)-Sobrerol
Pentacyclic triterpenoids have been reported in the literature from both plant and marine sources with moderate (μM) antitubercular activity [10] [11] [12] [13] [14] . Compound 2, in addition to other ubiquitous pentacyclic triterpenoids, such as ursolic acid, betulinic acid and betulin, have previously been isolated as the active components of many antitubercular plant extracts due to their activity against MTB [10] [11] [12] 14] . These results suggest that pentacyclic triterpenoids possess the minimum requirements for mild to moderate activity (mM to μM) against M. tuberculosis. Lead identification targeting M. tuberculosis growth inhibition from plant and marine sources should thus benefit from de-replication studies to determine the presence of such ubiquitous pentacyclic triterpenes prior to timeconsuming fractionation and isolation efforts. The activity was found concentrated in F002 (98% inhibition) and F003 showed only moderate activity (51% inhibition). Based on their similarity on TLC (silica gel, 50% EtOAc in n-hexane), F002 and F003 were combined. The combined F002 + F003 (56.7 g) was fractionated by column chromatography (silica gel, 1200 g, 63-200 μ, Scientific Adsorbents Incorporated) employing a gradient of EtOAc in n-hexane (0-90%) followed by a MeOH wash to give 44 fractions (F005-F048). F028 (0.3 g, 0.3%), eluting with 40% EtOAc in n-hexane, led to 70% MTB growth inhibition at a stock concentration of 50 μg/mL. F028 was fractionated using preparative silica gel plates (silica gel 60, 0.5 mm, 20 × 20 cm, concentration zone 20 × 4 cm, F 254 μ, Merck; 50% EtOAc in n-hexane; R f = 0.36). The PLC fraction containing compound 1 (0.031 g, 0.031%) was purified over a Sephadex LH-20 (Pharmacia Fine Chemicals, Piscataway, N.J.) column (length = 250 mm, width = 20 mm) leading to the isolation of compound 1 as a colorless oil (0.0127 g, 0.013%).
Experimental
The fraction eluting with 30% EtOAc in n-hexane (F015, 2 g, 2%) inhibited MTB growth by 91% at a concentration of 50 μg/mL. F015 showed one major spot on the TLC (Si gel, 50% EtOAc in n-hexane, R f = 0.9). The compound producing this spot was dissolved in MeOH and centrifuged. The filtrate was decanted and concentrated. On slow evaporation of solvent, white crystals of compound 2 (0.08 g, 0.08%), resembling cotton puffs were formed.
F038 (0.53 g, 0.53%), eluting with 60% EtOAc in n-hexane, led to a 73% growth inhibition of MTB at a concentration of 50 μg/mL. F038 was fractionated on a Sephadex LH-20 column (length = 250 mm, width = 20 mm), eluting with MeOH, and monitored by TLC. Further RPHPLC purification (C 18 , 5μ; 80% MeOH in H 2 O -100% MeOH, 12 min, 254 nm) resulted in the isolation of compound 3 (R t = 9.3 min) as a yellow powder (0.0018 g, 0.0018%).
Although F043 (0.74 g, 0.74%), eluting with 70% EtOAc in n-hexane, was ineffective in inhibiting the growth of MTB at the tested concentration of 50 μg/mL, it presented bright orange and pink spots on the TLC and was further fractionated to isolate these components (silica gel, 13 g, 62-120 μ, SAI; 0%-80% tonen n-hexane gradient). Fractions eluting with 15% acetone in n-hexane were further purified using RPHPLC ( 
Standard preparation for LC/MS study:
A 0.00144 g/mL solution of 2 in MeOH was adjusted to 0.000101 g/mL and transferred to a 2 mL HPLC vial. Similarly, 1 mL of 0.000106 g/mL and 0.0000994 g/mL of 4, and 5, respectively were prepared and transferred to 2 mL HPLC vials. 1 (0.00023 g) was dissolved in 500 μL MeOH and transferred to a 2 mL HPLC vial (at a concentration of 0.00046 g/mL). Each HPLC injection utilized 20 μL of these stock solutions.
Preparation of the (R)-and (S)-MTPA ester derivatives of 1:
The R and S Mosher's esters were prepared by a modification of the method described by Ohtani et al, as follows [15] . Compound 1 (0.0006 g) was dried in the fume hood and transferred into a clean and vacuum oven dried vial. Deuterated pyridine-d 5 (0.5 mL) and a catalytic amount of N,Ndimethyl-4-aminopyridine (DMAP, 0.0002 g), also completely dried under vacuum, were added to the vial and dissolved. The esterification was initiated by adding (S)-(+)-α-methoxy-α(trifluoromethyl)phenylacetyl (MTPA) chloride (0.001 g) into the vial under a continuous N 2 stream. The vial was then sealed and shaken to mix the reactants. The reaction was completed in 2 h at room temperature, as evidenced by TLC and 1 H NMR and yielded the (R)-MTPA ester derivative 1r of compound 1. The (S)-MTPA ester, 1s, was similarly prepared in another vacuum dried vial using (R)-(+)-α-methoxy-α-(trifluoromethyl) phenylacetyl (MTPA) chloride (0.001 g) and keeping all other reaction conditions the same as those mentioned above. The reaction was seen to be complete after 2 h, as monitored by 1 H NMR spectroscopy.
Microplate Alamar Blue assay:
The biological activities of the crude extract, chromatographic fractions and pure compounds were determined against M. tuberculosis H 37 Rv (ATCC 27294) using the Microplate Alamar Blue Assay (MABA), as previously described [16] . Percent inhibition was defined as 1 -(test well FU/mean FU of triplicate B wells) × 100. The lowest drug concentration effecting an inhibition of ≥ 90% was considered the MIC.
Vero cell cytotoxicity assay: All pure compounds that had antitubercular activity in the MABA were tested for cytotoxicity in the Vero Cell Cytotoxicity Assay, as previously described [17] . The IC 50 value is defined as the reciprocal dilution resulting in 50% inhibition of Vero cells. Maximum cytotoxicity (100%) was determined by lysing the cells with sodium dodecyl sulfate (Sigma Chemical Co., St. Louis, MO) [17] .
(1S,3S,4R)-1-Methyl-4-(1-methylethenyl)-1,3cyclohexanediol (3β-hydroxy-cis-β terpineol) (1)
[α] 22 D : 1.2º (c 0.60, CH 3 OH). IR (KBr) ν max : 3402, 2933, 1707, 1660, 1034 cm -1 . 1 H NMR: Table 1 . 13 C NMR: Table 1 . EIMS m/z: 170 (1), 152 (45), 137 (65), 119 (35), 109 (75), and 67 (100). Yield: 0.0127 g, 0.013%.
